Cargando…

53BP1: guarding the genome with a novel liquid weapon

In this Comment, Naveen Tangudu and Katherine Aird discuss recent findings showing that 53BP1 regulates heterochromatin through liquid-liquid phase separation.

Detalles Bibliográficos
Autores principales:	Tangudu, Naveen Kumar, Aird, Katherine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090828/ https://www.ncbi.nlm.nih.gov/pubmed/35538213 http://dx.doi.org/10.1038/s42003-022-03401-0

Ejemplares similares

The guards themselves
por: Petsko, Gregory A
Publicado: (2002)

Guarding a city from the COVID-19 pandemic
por: Xu, Jiuyang, et al.
Publicado: (2020)

Loss of p16: A Bouncer of the Immunological Surveillance?
por: Leon, Kelly E., et al.
Publicado: (2021)

Acoustic shock waves, a new weapon against angina?
por: van Hemel, N. M., et al.
Publicado: (2016)

p53 activation: a checkpoint for precision genome editing?
por: Conti, Anastasia, et al.
Publicado: (2018)

53BP1 regulates heterochromatin through liquid phase separation
por: Zhang, Lei, et al.
Publicado: (2022)

Guarding Against Catastrophic Biological Risks: Preventing State Biological Weapon Development and Use by Shaping Intentions
por: Yassif, Jaime M., et al.
Publicado: (2023)

A role of the 53BP1 protein in genome protection: structural and functional characteristics of 53BP1-dependent DNA repair
por: Bártová, Eva, et al.
Publicado: (2019)

Open questions on liquid–liquid phase separation
por: Spruijt, Evan
Publicado: (2023)

Comment on: The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
por: Schymik, Hanna S., et al.
Publicado: (2022)

Author Correction: 53BP1 regulates heterochromatin through liquid phase separation
por: Zhang, Lei, et al.
Publicado: (2022)

Reply to the Comment on “The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ”
por: Wang, Xia, et al.
Publicado: (2022)

Telomere Attrition and p53 Response 1 (TAPR1): a new player in cancer biology?
por: dos Santos, Gabriel Arantes, et al.
Publicado: (2021)

AHNAK controls 53BP1-mediated p53 response by restraining 53BP1 oligomerization and phase separation
por: Ghodke, Indrajeet, et al.
Publicado: (2021)

Triggering p53 after cytokinesis failure
por: Stukenberg, P. Todd
Publicado: (2004)

Phase separation of 53BP1 determines liquid‐like behavior of DNA repair compartments
por: Kilic, Sinan, et al.
Publicado: (2019)

DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
por: Leon, Kelly E., et al.
Publicado: (2021)

53BP1: a DSB escort
por: Mirman, Zachary, et al.
Publicado: (2020)

Editorial: Mechanisms guarding the genome
por: Brown, James A. L., et al.
Publicado: (2022)

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
por: Jiang, Liren, et al.
Publicado: (2020)

53BP1 contributes to a robust genomic stability in human fibroblasts
por: Fink, Lauren S., et al.
Publicado: (2011)

Delivering on the promise of early detection with liquid biopsies
por: Crosby, David
Publicado: (2022)

53BP1: keep an eye on merotely
por: Tang, Mengfan, et al.
Publicado: (2017)

TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
por: Bomben, Riccardo, et al.
Publicado: (2023)

Advances in liquid biopsy approaches for early detection and monitoring of cancer
por: Babayan, Anna, et al.
Publicado: (2018)

53BP1 is required for class switch recombination
por: Ward, Irene M., et al.
Publicado: (2004)

Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers
por: Li, Yi, et al.
Publicado: (2021)

Habitability and sub glacial liquid water on planets of M-dwarf stars
por: Wandel, Amri
Publicado: (2023)

Comment on Billant et al. p53, A Victim of the Prion Fashion. Cancers 2021, 13, 269
por: Liebman, Susan W., et al.
Publicado: (2023)

Around and beyond 53BP1 Nuclear Bodies
por: Fernandez-Vidal, Anne, et al.
Publicado: (2017)

Living Weapons: Biological Weapons and International Security
por: Cieslak, Theodore J.
Publicado: (2010)

Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative
por: Lau-Min, Kelsey S., et al.
Publicado: (2020)

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53
por: Napoli, Marco, et al.
Publicado: (2011)

Hidden weapons of microbial destruction in plant genomes
por: Manners, John M
Publicado: (2007)

Long noncoding RNAs: p53’s secret weapon in the fight against cancer?
por: Dangelmaier, Emily, et al.
Publicado: (2019)

"On guard at the gateway".
por: Taggart, J. M.
Publicado: (1967)

Phenytoin as a novel anti-vitiligo weapon
por: Namazi, MR
Publicado: (2005)

Novel technologies: A weapon against tuberculosis
por: Hari, B.N. Vedha, et al.
Publicado: (2010)

Metformin: A Novel Weapon Against Inflammation
por: Bai, Bo, et al.
Publicado: (2021)

Novel Plasmodium vivax genomes from Brazil identify targets for studies on drug resistance, transmission networks, and parasite evolution
por: Da Silva, Gustavo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pik4rvgn3oco4jn91kklhqupot